SAN DIEGO, Sept. 22 /PRNewswire/ — Biomatrica Inc., the leader
in room temperature biological sample stabilization, today
announced the release of DNAgard® Blood and DNAstable®
Blood.
DNAgard® Blood is a new addition to the “Gard” product line
for the stabilization and shipping of whole blood at ambient
temperatures. The DNAgard® Blood product is based on a
completely novel stabilization chemistry (patent pending) and
expands Biomatrica’s core technology to the stabilization of
patient blood samples (up to 10ml) to be used for genetic analysis.
DNAgard® Blood is designed to support the pre-analytics phase
(sample collection and shipping) of biomedical research, biobanking
& biorepositories, forensics as well as the fast growing
molecular diagnostic markets.
With the release of DNAgard Blood, whole blood samples (from 1
microliter to 10 milliliters) can be conveniently shipped and/or
stored in a liquid format for 3 months at ambient room temperature
prior to DNA extraction. This represents the longest storage time
point for an ambient condition stabilization of whole blood DNA on
the market. In addition, shipping temperatures of blood samples
stabilized by DNAgard Blood can range up to 45degC without any
impact on the DNA quality or yield.
“DNAgard Blood provides the longest room temperature
preservation of DNA in whole blood,” said Rolf Muller, Ph.D.,
Biomatrica’s Chief Scientific Officer and co-founder. “Researchers
can now easily, safely and cost effectively transport large volumes
of blood samples from point of care collection sites to the lab for
subsequent analysis without risk of sample quality diminishing.
Room temperature based biostability reagents offer a very
economical, eco-friendly solution to biological sample
preservation, transport and storage, thereby offering a paradigm
shift from traditional cold-freezing methods.”
DNAgard Blood will begin shipping to customers starting on
Sept
‘/>”/>
